Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019

BACKGROUND: Therapeutic options for hospitalized patients with severe coronavirus disease 2019 (sCOVID-19) are limited. Preliminary data have shown promising results with baricitinib, but real-life experience is lacking. We assessed the safety and effectiveness of add-on baricitinib to standard-of-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tziolos, Nikolaos, Karofylakis, Emmanouil, Grigoropoulos, Ioannis, Kazakou, Pinelopi, Koullias, Emmanouil, Savva, Athina, Kranidioti, Hariklia, Pelekanou, Aimilia, Boulouta, Anna, Pirounaki, Maria, Tsiodras, Sotirios, Georgiopoulos, Georgios, Boumpas, Dimitrios T, Kavatha, Dimitra, Thomas, Konstantinos, Vassilopoulos, Dimitrios, Antoniadou, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711791/
https://www.ncbi.nlm.nih.gov/pubmed/34988257
http://dx.doi.org/10.1093/ofid/ofab588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711791/
https://www.ncbi.nlm.nih.gov/pubmed/34988257
http://dx.doi.org/10.1093/ofid/ofab588

Ejemplares similares